Nihon Kohden Corporation (OTCMKTS:NHNKY) Short Interest Down 55.6% in July

Nihon Kohden Corporation (OTCMKTS:NHNKY) was the recipient of a significant decline in short interest in the month of July. As of July 15th, there was short interest totaling 6,349 shares, a decline of 55.6% from the June 30th total of 14,284 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 45,861 shares, the short-interest ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy”.

Nihon Kohden Price Performance

NHNKY traded up $0.16 during trading on Tuesday, hitting $9.86. 8,882 shares of the stock traded hands, compared to its average volume of 28,423. The firm has a market capitalization of $1.66 billion, a P/E ratio of 16.71 and a beta of 0.39. The firm has a 50-day moving average of $9.03 and a 200 day moving average of $9.86. Nihon Kohden has a 12-month low of $8.12 and a 12-month high of $14.21.

Nihon Kohden (OTCMKTS:NHNKY) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.10. The firm had revenue of $453.10 million for the quarter, compared to analysts’ expectations of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. As a group, equities analysts predict that Nihon Kohden will post 0.6 EPS for the current fiscal year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.